These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1685785

  • 41. Effect of atrial natriuretic peptide on apomorphine-induced stereotyped cage-climbing behavior in mice.
    Bidzseranova A, Gueron J, Tóth G, Penke B, Telegdy G.
    Eur J Pharmacol; 1992 Feb 18; 211(3):411-4. PubMed ID: 1352255
    [Abstract] [Full Text] [Related]

  • 42. Suppression of luteinizing hormone secretion by atrial and brain natriuretic peptides in ovariectomized rats.
    Zhang J, Yuen BH, Currie WD, Leung PC.
    Endocrinology; 1991 Aug 18; 129(2):801-6. PubMed ID: 1830270
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H.
    Circulation; 1993 Feb 18; 87(2):554-61. PubMed ID: 8381060
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Antidipsogenic action of a novel peptide, 'brain natriuretic peptide', in rats.
    Itoh H, Nakao K, Yamada T, Shirakami G, Kangawa K, Minamino N, Matsuo H, Imura H.
    Eur J Pharmacol; 1988 May 20; 150(1-2):193-6. PubMed ID: 2969822
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor.
    Hansell P, Fasching A, Sjöquist M, Andén NE, Ulfendahl HR.
    Acta Physiol Scand; 1987 Jul 20; 130(3):401-7. PubMed ID: 2957892
    [Abstract] [Full Text] [Related]

  • 59. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P, Vuolteenaho O, Ruskoaho H.
    Endocrinology; 1992 Feb 20; 130(2):755-65. PubMed ID: 1531129
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.